PTC THERAPEUTICS, INC. · Secaucaus, New Jersey
Case #I-200-20131-557643
PTC THERAPEUTICS, INC. filed an H-1B petition for a Scientist I, Analytical Development - Gene Therapy position in Secaucaus, New Jersey at $105k per year — 27% above the prevailing wage of $83k. The case was certified in 820 days during the FY FY2020 cycle. This position is for new employment.
| Case Number | I-200-20131-557643 |
| Case Status | Certified - Withdrawn |
| Visa Class | H-1B |
| Fiscal Year | FY 2020 |
| Employer | PTC THERAPEUTICS, INC. |
| Employer Location | SOUTH PLAINFIELD, New Jersey |
| Job Title | Scientist I, Analytical Development - Gene Therapy |
| SOC Code | 19-104200 – Medical Scientists, Except Epidemiologists |
| Worksite | Secaucaus, New Jersey |
| Annual Wage | $105k |
| Prevailing Wage | $83k |
| Wage Premium | +27.0% |
| Positions | 1 (1 new, 0 continued) |
| Job Title | Salary | Status | Date |
|---|---|---|---|
| Principal Scientist, Formulation Development | $149k | CERTIFIED | Jun 11, 2025 |
| Senior Manager, People Systems | $145k | CERTIFIED | May 21, 2025 |
| Scientist I, Multiomics Analysis | $117k | CERTIFIED | May 1, 2025 |
| Manager, Clinical Operations | $115k | CERTIFIED | Apr 29, 2025 |
| Associate Scientist II, Multiomics Analysis | $95k | CERTIFIED | Apr 26, 2025 |
This Labor Condition Application (LCA) was filed by PTC THERAPEUTICS, INC. for the position of Scientist I, Analytical Development - Gene Therapy in Secaucaus, New Jersey. The offered annual salary is $105k, compared to the prevailing wage of $83k for this occupation and location. This represents a wage premium of +27.0% above the prevailing wage.
The LCA is the first step in the H-1B visa process. Employers must file an LCA with the Department of Labor certifying that they will pay the foreign worker at least the prevailing wage for the occupation in the area of intended employment. A certified LCA is required before the employer can file an H-1B petition with USCIS.
Case status: Certified - Withdrawn. This means the employer or their representative withdrew the application.
A Labor Condition Application (LCA) is a mandatory document that U.S. employers must file with the U.S. Department of Labor (DOL) before they can petition for a foreign worker under the H-1B, H-1B1, or E-3 visa categories. The LCA process was established under the Immigration and Nationality Act (INA) to protect both foreign and domestic workers by ensuring fair wages and working conditions.
When a U.S. company identifies a foreign national to fill a specialty occupation position, they must first obtain DOL certification through the LCA process before filing the H-1B petition (Form I-129) with U.S. Citizenship and Immigration Services (USCIS). In this case, PTC THERAPEUTICS, INC. filed LCA case number I-200-20131-557643 to sponsor a Scientist I, Analytical Development - Gene Therapy position at their worksite in Secaucaus, New Jersey. By filing this LCA, the employer attests to four key conditions: (1) paying the higher of the actual wage or prevailing wage, (2) providing working conditions that will not adversely affect other similarly employed workers, (3) no strike or lockout at the worksite, and (4) providing notice of the filing to the bargaining representative or posting notice at the worksite.
The DOL establishes four wage levels for each occupation and geographic area, representing the progression from entry-level to fully competent workers:
For this filing, the offered wage of $105k compares to the DOL prevailing wage of $83k for Medical Scientists, Except Epidemiologists positions in the Secaucaus, New Jersey area. The positive wage premium of +27.0% indicates the employer is offering above the DOL-determined average for this occupation and location.
The prevailing wage is the average wage paid to similarly employed workers in a specific occupation in the area of intended employment. The DOL determines prevailing wages using data from the Occupational Employment and Wage Statistics (OEWS) survey conducted by the Bureau of Labor Statistics (BLS). Employers must pay H-1B workers the higher of the prevailing wage or the actual wage paid to other employees in similar positions at the company. This requirement is designed to prevent employers from using H-1B workers to undercut domestic wages.
A "Certified-Withdrawn" status means this LCA was initially certified by the DOL but was later withdrawn by the employer. This can happen for various reasons: the foreign worker may have declined the position, found employment elsewhere, the employer may have decided to refile with updated information, or business conditions may have changed. A withdrawal does not negatively affect the employer's ability to file future LCAs.
This LCA was received by the DOL on May 10, 2020 and a decision was rendered on Aug 8, 2022, a processing time of approximately 820 business days. The standard DOL processing time for LCA applications is 7 to 10 business days. This application took longer than the standard timeframe, which may indicate additional review was required.
The offered salary of $105k for this Scientist I, Analytical Development - Gene Therapy position provides a data point for evaluating compensation trends in H-1B visa sponsorship. When reviewing H-1B salary data, consider that wages vary significantly based on geographic location, employer size, industry sector, and the worker's experience level. This position falls under SOC code 19-104200 (Medical Scientists, Except Epidemiologists), which standardizes how the Bureau of Labor Statistics classifies occupations across industries. Metropolitan areas like New York, San Francisco, and Seattle typically command higher salaries due to higher costs of living, while positions in smaller markets may offer lower nominal wages but comparable purchasing power.
The offered annual salary for this Scientist I, Analytical Development - Gene Therapy position at PTC THERAPEUTICS, INC. is $105k. The Department of Labor prevailing wage for this occupation and location is $83k. The offered wage represents a +27.0% premium over the prevailing wage.
This H-1B filing is for a position located in Secaucaus, New Jersey. The employing company, PTC THERAPEUTICS, INC., is headquartered in SOUTH PLAINFIELD, New Jersey.
This Labor Condition Application is filed under the H-1B visa classification. The H-1B visa is designed for specialty occupation workers who possess at least a bachelor's degree or equivalent in a specific field related to the job.
The employer for this filing is PTC THERAPEUTICS, INC., located in SOUTH PLAINFIELD, New Jersey. PTC THERAPEUTICS, INC. filed this Labor Condition Application (case number I-200-20131-557643) for a Scientist I, Analytical Development - Gene Therapy position during fiscal year FY 2020. View all PTC THERAPEUTICS, INC. H-1B filings.
Certified-Withdrawn means this LCA was initially certified by the DOL but was subsequently withdrawn by the employer or their authorized representative.